ストックスクリーナーアプリを入手
132.82
4.67%
-6.58
アフターアワーズ：
132.63
-0.19
-0.14%
前日終値:
$139.40
開ける：
$138.88
24時間の取引高:
1.19M
Relative Volume:
1.71
時価総額：
$7.48B
収益：
$633.51M
当期純損益:
$-8.10M
株価収益率:
-428.45
EPS:
-0.31
ネットキャッシュフロー:
$131.26M
1週間 パフォーマンス:
-4.85%
1か月 パフォーマンス:
-21.09%
6か月 パフォーマンス:
+9.46%
1年 パフォーマンス:
-8.80%
1日の値動き範囲:
$130.40
$140.45
1週間の範囲:
$130.40
$146.36
52週間の値動き範囲:
$102.97
$175.77
Repligen Corp Stock (RGEN) Company Profile
Compare RGEN vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
132.83 | 7.85B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
478.34 | 176.19B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
177.83 | 51.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
78.54 | 39.00B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
44.59 | 37.48B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
245.84 | 37.82B | 5.40B | 1.49B | 1.78B | 10.12 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-01 | 開始されました | HSBC Securities | Buy |
| 2025-09-22 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-07-22 | 再開されました | Stephens | Overweight |
| 2025-06-24 | 開始されました | Barclays | Overweight |
| 2025-04-29 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | 開始されました | Evercore ISI | In-line |
| 2025-02-10 | 開始されました | TD Cowen | Buy |
| 2024-12-17 | 開始されました | Canaccord Genuity | Hold |
| 2024-11-14 | 開始されました | Wolfe Research | Peer Perform |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-26 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-06-18 | 開始されました | Guggenheim | Neutral |
| 2023-12-04 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2023-07-20 | 開始されました | Wells Fargo | Overweight |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-03-28 | 開始されました | The Benchmark Company | Buy |
| 2022-12-14 | 開始されました | Deutsche Bank | Hold |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | 開始されました | UBS | Buy |
| 2021-10-14 | 開始されました | Exane BNP Paribas | Outperform |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-07 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-23 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-11-01 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | 開始されました | SVB Leerink | Outperform |
| 2019-08-28 | 繰り返されました | First Analysis Sec | Outperform |
| 2019-08-23 | 再開されました | Stephens | Overweight |
| 2019-07-22 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | アップグレード | CL King | Neutral → Buy |
| 2018-11-12 | ダウングレード | CL King | Buy → Neutral |
| 2018-09-26 | 開始されました | H.C. Wainwright | Neutral |
| 2017-12-08 | 開始されました | Citigroup | Buy |
| 2017-12-05 | 開始されました | JP Morgan | Overweight |
| 2017-11-13 | 開始されました | CL King | Buy |
| 2017-10-02 | アップグレード | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | 開始されました | William Blair | Outperform |
| 2017-02-13 | アップグレード | Piper Jaffray | Neutral → Overweight |
すべてを表示
Repligen Corp (RGEN) 最新ニュース
Impax Asset Management Group plc Reduces Position in Repligen Corporation $RGEN - MarketBeat
Repligen to Report Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Bessemer Group Inc. Sells 238,450 Shares of Repligen Corporation $RGEN - Defense World
Repligen (NASDAQ:RGEN) Upgraded to "Buy" at Wall Street Zen - MarketBeat
What Makes Repligen Corporation (RGEN) an Investment Choice? - Yahoo Finance
Repligen is Now Oversold (RGEN) - Nasdaq
A Look At Repligen (RGEN) Valuation As Ordering Stabilizes And Growth Segments Progress - Yahoo Finance
Repligen Corp (RGEN) Stock Price Down 3.37% on Jan 29 - GuruFocus
Head-To-Head Comparison: Repligen (NASDAQ:RGEN) vs. Abpro (NASDAQ:ABP) - Defense World
3 Reasons to Sell RGEN and 1 Stock to Buy Instead - Finviz
Pharma News: Can Repligen Corporation navigate macro headwindsMarket Sentiment Review & Safe Entry Point Identification - mfd.ru
UBS Tags Repligen (RGEN) as Bioprocessing Leader for 2026, Cites 20% Order Growth and Reshoring Tailwinds - Insider Monkey
Repligen Corporation (NASDAQ:RGEN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Repligen Corp (RGEN) Shares Up 3.89% on Jan 21 - GuruFocus
Single-Use Bioprocessing Market Projected to Reach US$ 122.92 Billion by 2035, Supported by Expansion of Biomanufacturing Capacity Says Astute Analytica - GlobeNewswire Inc.
Slow Capital Inc. Has $5.89 Million Holdings in Repligen Corporation $RGEN - MarketBeat
Is It Too Late To Consider Buying Repligen Corporation (NASDAQ:RGEN)? - Yahoo Finance
Stephens Investment Management Group LLC Grows Stock Position in Repligen Corporation $RGEN - MarketBeat
Expert Outlook: Repligen Through The Eyes Of 5 Analysts - Benzinga
UBS raises Repligen stock price target to $200 on bioprocessing recovery - Investing.com
Why Repligen (RGEN) Shares Are Sliding Today - Finviz
Repligen Corp. Seeks M&A Opportunities - marketscreener.com
Published on: 2026-01-13 17:35:09 - Bộ Nội Vụ
Conestoga Capital Advisors LLC Has $127.91 Million Position in Repligen Corporation $RGEN - Defense World
Is Repligen Corporation stock gaining market share2025 Volatility Report & Growth Oriented Trading Recommendations - ulpravda.ru
Can Repligen Corporation stock hit record highs againJuly 2025 Levels & AI Powered Market Trend Analysis - Улправда
Repligen appoints Madaus as new board chair, Hunt to retire By Investing.com - Investing.com Canada
Repligen appoints Madaus as new board chair, Hunt to retire - Investing.com
Repligen Corporation Elects Dr. Martin D. Madaus as New Chair of the Board, Succeeding Tony Hunt - Quiver Quantitative
Repligen Corp Announces New Chair of the Board - TradingView — Track All Markets
Longtime Repligen leader steps down as new board chair takes over in 2026 - Stock Titan
Repligen Corporation (RGEN): Investor Outlook with a 15% Upside Potential in the Bioprocessing Sector - DirectorsTalk Interviews
Institution Moves: How risky is Repligen Corporation RGN stock compared to peersMarket Risk Report & Risk Controlled Stock Pick Alerts - Bộ Nội Vụ
About Us - FinancialContent
Pacer Advisors Inc. Has $1.37 Million Position in Repligen Corporation $RGEN - MarketBeat
Allspring Global Investments Holdings LLC Lowers Stake in Repligen Corporation $RGEN - MarketBeat
Bioprocess Filtration Global Markets Report 2025-2030, Profiles of Leading PlayersDanaher, Merck, Sartorius, Solventum, and RepligenResearchAndMarkets.com - Business Wire
Delta Investment Management LLC Buys Shares of 50,717 Repligen Corporation $RGEN - MarketBeat
Repligen Corporation (NASDAQ:RGEN) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Why Repligen Corporation stock remains undervaluedFibonacci Retracement Levels & Free Dynamic Capital Growth - bollywoodhelpline.com
Is Repligen (RGEN) Quietly Recasting Its Gene Therapy Moat With New HiPer Viral Vector Resins? - simplywall.st
Riverbridge Partners LLC Sells 24,644 Shares of Repligen Corporation $RGEN - MarketBeat
Congress Asset Management Co. Boosts Stake in Repligen Corporation $RGEN - Defense World
Assenagon Asset Management S.A. Takes Position in Repligen Corporation $RGEN - MarketBeat
Can Repligen Corporation stock maintain growth trajectoryFed Meeting & Smart Allocation Stock Tips - Улправда
Texas Permanent School Fund Corp Has $3.13 Million Stock Holdings in Repligen Corporation $RGEN - MarketBeat
Will Repligen Corporation stock rally after Fed decisions2025 Winners & Losers & Free Technical Pattern Based Buy Signals - Улправда
Why Repligen Corporation (RGN) stock trades below fair valueJuly 2025 Drop Watch & Risk Managed Investment Signals - Bölüm Sonu Canavarı
Repligen (RGEN): Assessing Valuation After New Chromatography Resins Expand Its Gene Therapy Toolkit - simplywall.st
Repligen Corp (RGEN) 財務データ
収益
当期純利益
現金流量
EPS
Repligen Corp (RGEN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| MUIR GLENN P | Director |
Dec 16 '25 |
Option Exercise |
26.12 |
3,366 |
87,920 |
36,622 |
6.69%
大文字化:
|
ボリューム (24 時間):